MAPT and Alzheimer disease: Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by the progressive loss of cognitive function and independence, with extracellular plaque deposits of the β-amyloid peptide (Aβ) and flame-shaped neurofibrillary tangles of the microtubule-binding protein tau.